Related Experiment Video
Updated: Jul 11, 2026

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Comments on an in vitro model of hormonally refractory prostate cancer
J L Joyal1, D I Israel, M B Garnick
1Praecis Pharmaceuticals Inc, Harvard Medical School, Cambridge, Massachusetts 02139, USA.
Cancer Journal (Sudbury, Mass.)
|October 19, 2000
Abstract
No abstract available in PubMed .

